Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine vs Valproate in Rapid Cycling Bipolar Disorder
NCT00254774Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in bipolar disorder (BD), sponsored by AstraZeneca. Started Jan 2002; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00254774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254774.